Zai Lab

Zai Lab Tangible Book Value per Share

The Tangible Book Value per Share of Zai Lab (9688.HK) as of Nov 2, 2026 is 0.72 USD. In the previous year, Tangible Book Value per Share was 0.79 USD — a change of -8.51% (lower).

Tangible Book Value per Share

0.72USD

YoY

-8.51%

Last updated:

Tangible Book Value per Share of Zai Lab is 2025 0.72 USD. Tangible Book Value per Share of Zai Lab was 2024 0.79 USD. It decreases by -8.51% lower compared to the previous year.

The Zai Lab Tangible Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Tangible Book Value per Share
Date
Tangible Book Value per Share
Jan 1, 2018
0.25 USD
Jan 1, 2019
0.29 USD
Jan 1, 2020
1.17 USD
Jan 1, 2021
1.38 USD
Jan 1, 2022
1.05 USD
Jan 1, 2023
0.79 USD
Jan 1, 2024
0.79 USD
Jan 1, 2025
0.72 USD
The Zai Lab Tangible Book Value per Share history
YEARTangible Book Value per ShareYoY
0.72USD-8.51%
0.79USD+0.30%
0.79USD-24.83%
1.05USD-24.31%
1.38USD+18.13%
1.17USD+305.77%
0.29USD+13.99%
0.25USD+6.64%
0.24USD-556.18%
-0.05USD+180.63%
-0.02USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Zai Lab Stock analysis

What does Zai Lab do? Zai Lab Ltd. focuses on discovering, developing, and commercializing proprietary therapeutics for unmet medical needs in China, particularly in oncology, autoimmune, and infectious diseases. The company's pipeline includes drug candidates such as Niraparib (ZL-2306), ZL-2103, and ZL-1101, which are in various stages from discovery to late-stage clinical programs. Its products target large patient segments requiring innovative treatments within the Chinese healthcare market. The firm's revenue comes from the commercialization of its proprietary drug candidates, which are developed through internal research and strategic partnerships. Zai Lab Ltd. serves the Chinese biopharmaceutical market, targeting healthcare providers, hospitals, and patients seeking advanced therapies for conditions like cancer and autoimmune disorders. The company leverages its pipeline to generate sales through pharmaceutical distribution channels in China. Zai Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zai Lab stock

Tangible Book Value per Share of Zai Lab is 0.72 USD in 2025.

Tangible Book Value per Share of Zai Lab changed from 0.79 USD to 0.72 USD, representing a -8.51% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Tangible Book Value per Share Zai Lab since 2006 – with annual values, charts, and detailed analysis.

Tangible book value per share excludes intangible assets and goodwill, providing a more conservative measure of per-share net asset value.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Zai Lab

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Zai Lab